Paper Details
- Home
- Paper Details
Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy.
Author: ClyneColin D, GaillardStéphanie, KovacicAgnes, McDonnellDonald P, MurataYoko, SafiRachid, SimpsonEvan R
Original Abstract of the Article :
Aromatase inhibitors target the production of estrogen in breast adipose tissue, but in doing so, also decrease estrogen formation in bone and other sites, giving rise to deleterious side effects, such as bone loss and arthralgia. Thus, it would be clinically useful to selectively inhibit aromatase ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1158/0008-5472.CAN-05-2792
データ提供:米国国立医学図書館(NLM)
Aromatase Inhibition: A Quest for Breast Cancer Specificity
This study, published in [Journal Name], explores the intricacies of aromatase inhibition, a key strategy in breast cancer therapy. The researchers meticulously investigate the role of the orphan nuclear receptor liver receptor homologue-1 (LRH-1) and its coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) in regulating aromatase gene expression.The Intricate Regulation of Aromatase
The study unveils the complex regulation of aromatase gene expression, highlighting the crucial roles of LRH-1 and PGC-1alpha in this process. The research team identifies a potential pathway for selectively inhibiting aromatase production in breast tissue while sparing other sites of expression, paving the way for more targeted and less-invasive therapies.A New Frontier in Breast Cancer Treatment
This research opens up exciting new avenues for breast cancer treatment. By understanding the molecular mechanisms underlying aromatase regulation, we can develop more specific and effective therapies, minimizing side effects and improving patient outcomes.Dr. Camel's Conclusion
This study underscores the remarkable power of molecular research in developing precise and personalized therapies. By carefully navigating the intricate network of cellular pathways, we can gain valuable insights into disease mechanisms and design targeted treatments that minimize collateral damage.Date :
- Date Completed 2006-02-23
- Date Revised 2018-12-03
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.